Clinical trial · Interventional
Mohs Surgery Combind With Cryotherapy for Eyelid Malignant Tumors.
Mohs Surgery Combind With Cryotherapy for Eyelid Malignant Tumors: a Prospective Randomized Controlled Study.
NCT05072327CI-TRIAL-00054343unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study aim to investigate whether the prognosis of eyelid malignant tumor is better treated with Mohs surgery combind with cryotherapy than Mohs surgery only.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Eyelid Tumor | Eyelid Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| cryotherapy | Procedure | — | UNRESOLVED |
| Mohs surgery | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Mohs surgery conbind with cryotherapy
- description
- patients in this group received both Mohs surgery and cryotherapy.
- interventionNames
- Procedure: Mohs surgery
- Procedure: cryotherapy
- type
- ACTIVE_COMPARATOR
- label
- Mohs surgery
- description
- patients in this group received only Mohs surgery.
- interventionNames
- Procedure: Mohs surgery
Primary outcomes (2)
- measure
- recurrence rate of tumor
- timeFrame
- three years
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: * Ability to provide written informed consent and comply with study assessments for the full duration of this study. * Definite pathology signs of eyelid basal cell carcinoma, squamous cell carcinoma and sebacous carcinoma, Stage Tis to T3CN0M0 based on American Joint Committee on Cancer. * Pathological examination showed the primary tumor was compeletely resected Exclusion Criteria: * Any previous treatment in the study eye * Tumor complicated with infection * Any other tumors of the paticipants * Intolerate of surgery or anesthesia
References
Publications (0)
Data not yet available
No reference posted for this study.